Featured News

The University of Kansas is helping to develop both a Lyme disease vaccine and a Chlamydia vaccine with Lawrence born biotechnology lab, Design-Zyme, and the projects all started with help from a KU graduate student. Peter Petillo, Design-Zyme founder and CEO, and Professor Scott Hefty, from the KU school of molecular biosciences, act as the foundation for a partnership between university and industry.

The woods can be a place of adventure and beauty, a peaceful escape for a walk. But among the leaves and grass, the threat of ticks can turn a hike into a health-altering encounter with Lyme disease. A recent $3 million Small Business Innovation Research award will fund the research and development of a vaccine to stop Lyme disease in its tracks.

The Department of Chemistry congratulates Professor Jon Tunge on receiving the August 2024 Walter and Roy Cross Professional Service Award!

Hyunjoon Kim, CBID research project leader and Assistant Professor of Pharmaceutical Chemistry, was awarded $25,000 by University of Kansas Medical Center Research Institute to study "Novel TLR7/8 agonists for bladder cancer immunotherapy".

Shyam Sathyamoorthi, Associate Professor of Medicinal Chemistry and CBID research project leader graduate, won a new award from Kansas State University. This award will provide $76,500 to study "Illuminating Dark Antibiotics: A Novel Synthesis of Streptothricin F and First Total Synthesis of BD-12 and Albothricin".